Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ADIPOQ; adiponectin gene; DM; diabetes mellitus; HOMA-IR; homeostasis model assessment of insulin resistance; IDF; International Diabetes Federation; MAF; minor allele frequency; SNPs; single nucleotide polymorphisms; T1DM; type 1 diabetes mellitus; T2DM;
مقالات ISI ارزیابی مدل هومیوستاز مقاومت به انسولین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; obesity; fatty pancreas; insulin resistance; ALP; Alkaline phosphatase; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; BMI; Body mass index; CT; Computed tomography; HbA1C; Glycated hemoglobin; HDL; High-density lipoprotein; HOMA-IR; Home
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; AST; aspartate aminotransferase; ALT; alanine aminotransferase; BIA; bioelectrical impedance analyzer; BMI; body mass index; BP; blood pressure; CAD; coronary artery disease; CI; confidence interval; CVD; cardiovascular disease; FFQ; food frequency questi
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Diabetes; Insulin resistance; Dyslipidemia; TG to HDL-C ratio; BMI; body-mass index; WC; waist circumference; FPG; fasting plasma glucose; HbA1c; Hemoglobin A1c; TG; triglycerides; TC; total cholesterol; HDL-C; high-density lipoprotein cholesterol; LDL-C;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; NIC; nicotine; JAK2; janus tyrosine kinase; STAT3; signal transducer and activator of transcription 3; SOCS3; suppressor of cytokine signaling 3; OB-R; leptin receptors; GD; gestational day; isSWAT; interscapular subcutaneous white adipose tissue; igSWAT;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BC; black carbon; HbA1c; hemoglobin A1c; HOMA-IR; homeostasis model assessment of insulin resistance; NOx; nitrogen oxides; O3; ozone; PM2.5; fine particulate matter; SO42Â â; Â sulfate; Air pollution; Adipokines; Glucose homeostasis; Epidemiology; Part
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ADMA; asymmetric dimethylarginine; CVD; cardiovascular disease; DDAH; dimethylarginine dimethylaminohydrolase; HOMA; homeostasis model assessment of insulin resistance; A; aorta; MA; mesenteric artery; CA; coronary artery; CC; penile corpus cavernosum; SN
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; T2DM; Type 2 diabetes mellitus; STZ; Streptozotocin; NA; Nicotinamide; (i.p.); Intraperitoneal; IPGTT; Intraperitoneal glucose tolerance test; TC; Total cholesterol; TG; Triglyceride; HDL; High-density lipoprotein-cholesterol; LDL-C; Low-density lipoprote
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Autonomic nervous system; Sympathectomy; Endocrine pancreas; Insulin release; Metabolism; Alpha-2 adrenergic receptor; 4-DAMP; 4-diphenylacetoxy-N-methylpiperidine methiodide; ACh; acetylcholine; α2AR; alpha-2 adrenergic receptor; ADRA2A; alpha-2 adrener
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Cardiovascular magnetic resonance; Proton magnetic resonance spectroscopy; Metabolic syndrome; Obesity; Left atrial; Ejection fraction; Atrial remodeling; Visceral adipose tissue; Cardiac steatosis; 3ch; three-chamber; AF; atrial fibrillation; ATP; adenos
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Sleep fragmentation; Intermittent hypoxia; Interaction; Abnormal glycometabolism; OSA; obstructive sleep apnea; SF; sleep fragmentation; IH; intermittent hypoxia; SDB; sleep-disordered breathing; BMI; body mass index; ROS; reactive oxygen species; PSG; po
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Sugars; Free sugar; Metabolic; Inflammation; Glycaemia; CRP; C-reactive protein; HbA1c; glycated haemoglobin; FFQ; food frequency questionnaire; HOMA-IR; homeostasis model assessment of insulin resistance; EPIC; The European Prospective Investigation into
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BMI; body mass index; CT; computed tomography; HOMA-IR; homeostasis model assessment of insulin resistance; IFG; impaired fasting glucose; IGT; impaired glucose tolerance; LAM; low-attenuation muscle; NAM; normal-attenuation muscle; OGTT; oral glucose tol
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BMI; body mass index; HOMA; homeostasis model assessment of insulin resistance; IGF-1; insulin-like growth factor-1; NSAID; nonsteroidal anti-inflammatory drug; SAT; subcutaneous adipose tissue; VAT; visceral adipose tissue; WC; waist circumference;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Nighttime sleep duration; Midday naps; Glycemic control; Type 2 diabetes; BMI; body mass index; SBP; systolic blood pressure; DBP; diastolic blood pressure; FPG; fasting blood glucose; HbA1c; hemoglobin A1c; HDL; high-density lipoprotein; HOMA-2%B; homeos
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; AIP; atherogenic index of plasma; BMI; body mass index; HDL-C; high density lipoprotein-cholesterol; HOMA-IR; homeostasis model assessment of insulin resistance; HOMA-%B; homeostasis model assessment of beta cell function; Hcy; Homocysteine; QUICKI; quant
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Coronary artery calcification; Correlation; Gallstone; Risk factors; BMI; body mass index; CAC; coronary artery calcification; CAD; coronary artery disease; CVD; cardiovascular disease; HOMA-IR; homeostasis model assessment of insulin resistance; hsCRP; h
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; postprandial; cholesterol; insulin; glucose; cardiometabolic; blood tests; BMI; Body mass index; HDL; High-density lipoprotein; HOMA-IR; Homeostasis model assessment of insulin resistance; LDL; Low-density lipoprotein; NHANES; National Health and Nutritio
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; adolescents; bariatric surgery; obesity; NAFLD; AHI; Apnea/hypopnea index; BIB; BioEnterics Intragastric Balloon System; BMI; Body mass index; HOMA-IR; Homeostasis model assessment of insulin resistance; IGWLD; Intragastric weight loss devices; LSG; Lapar
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ALT; serum alanine transaminase; AST; serum aspartate transaminase; AKT; protein kinase B; FBG; fasting blood glucose; Glut4; glucose transporter type 4; GSP; glucosylated serum protein; HOMA-IR; homeostasis model assessment of insulin resistance; INS; se
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Gestational sleep fragmentation; Integrated stress response; Metabolic syndrome; Insulin-resistance; Exosomes; CHOP; C/EBP homologous protein; DM; double mutant; ER; endoplasmic reticulum; eIF2α; eukaryotic initiation factor 2; FoxP3 +;  Forkhead box P
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ALT; alanine aminotransferase; C/EBPα; CCAAT/enhancer binding protein alpha; CHOP; CCAAT-enhancer-binding protein homologous protein; CYP2E1; cytochrome P450 2E1; DAMPs; danger-associated molecular patterns; FABP1; fatty acid binding protein 1; FAS; fatt
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BPH; Benign Prostatic Hyperplasia; IGF-1; insulin like growth factor-1; IGFBP-3; insulin like growth factor binding protein - 3; HOMA-IR; homeostasis model assessment of insulin resistance; Benign Prostatic Hyperplasia; Insulin; Insulin like growth fact
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ADA; American Diabetes Association; AUC; area under the curve; BMI; body mass index; CD; cluster of differentiation; CI; confidence interval; CRP; C-reactive protein; CV; cardiovascular; DSS-II; 2nd Diabetes Surgery Summit; ELISA; enzyme-linked immunosorb
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; DLK1; delta-like 1 homolog; DOHaD; developmental origins of health and disease, DPP-4, dipeptidyl peptidase-4; ERK; extracellular signal-regulated kinase; GGCX; γ-glutamyl carboxylase; GLP-1; glucagon-like peptide-1; GlaOC; γ-carboxylated osteocalcin; G
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Serum immunoglobulin; Prediabetes; Cross-sectional study; IFG; impaired fasting glucose; IGT; impaired glucose tolerance; HbA1c; glycosylated hemoglobin; CVD; cardiovascular disease; NF-κB; nuclear factor-κB; Igs; immunoglobulins; T2D; type 2 diabetes;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; MetS; metabolic syndrome; GFR; glomerular filtration rate; ROS; reactive oxygen species; Ox-LDL; oxidized low-density lipoprotein; ELAM; elamipretide; mPTP; mitochondrial permeability transition pore; PBS; phosphate-buffered saline; PRA; plasma renin acti
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Gestational diabetes mellitus; Capsaicin; Glucose metabolism; Calcitonin gene-related peptide; Large-for-gestational-age newborns; 2-h HOMA-IR; 2-hour postprandial HOMA-IR; 2-h INS; 2-hour postprandial serum insulin; 2-h PG; 2-hour postprandial plasma glu
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BMI; Body mass index; BP; Blood pressure; DEHP; Di-(2-ethylhexyl) phthalate; EMPs; Endothelial microparticles; hs-CRP; High-sensitivity C-reactive protein; HDL-C; High-density lipoprotein cholesterol; HOMA; Homeostasis model assessment of insulin resistan
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; 8-OHdG; 8-hydroxydeoxyguanosine; BMI; body mass index; CIMT; carotid intima-media thickness; SBP and DBP; systolic and diastolic blood pressure; EMPs; endothelial microparticles; hs-CRP; high sensitivity C-reactive protein; HDL-C; high-density lipoprotein
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BMI; body mass index; CB; common buckwheat; DC; diet control; HbA1c; glycated hemoglobin; HDL-c; high-density lipoprotein cholesterol; HOMA-IR; homeostasis model assessment of insulin resistance; LDL-c; low-density lipoprotein cholesterol; MetS; metabolic
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; AUC-ROC; area under the curve in a receiver operating characteristic curve; BMI; body mass index; HOMA-IR; homeostasis model assessment of insulin resistance; HOMA-β; homeostasis model assessment of β cell function; IR; insulin resistance; NHANES; Natio
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; β-AR; β-adrenergic receptor; 4-HNE; 4-hydroxynonenal; ACC; acetyl-coA carboxylase; ALT; alanine aminotransferase; AMPK; adenosine monophosphate-activated protein kinase; ANOVA; analysis of variance; AST; aspartate transaminase; ATGL; adipose triglycerid
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ALT; alanine transaminase; AST; aspartate transaminase; BMI; body mass index; CBT; cognitive behavioral therapy; HOMA-IR; homeostasis model assessment of insulin resistance; HCC; hepatocellular carcinoma; IHTG; intrahepatic triglycerides; MR-S; magnetic r
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; PCOS; polycystic ovary syndrome; INSL3; insulin-like factor 3; RXFP2; relaxin/insulin-like family peptide receptor-2; GDF-9; growth differentiation factor 9; BMI; body mass index; WHR; waist to hip ratio; FBS; fasting blood glucose; OGTT; oral glucose-tol
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; apoA-1; apolipoprotein A-1; apoB; apolipoprotein B-100; CEC; cholesterol efflux capacity; CVD; cardiovascular disease; HDL; high-density lipoprotein; HOMA-IR; homeostasis model assessment of insulin resistance; LDL; low-density lipoprotein;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; adenotonsillectomy; children; insulin resistance; lipids; OSA; AHI; apnea-hypopnea index; CHAT; Randomized Controlled Study of Adenotonsillectomy for Childhood Sleep Apnea; CV; coefficient of variation; FPG; fasting plasma glucose; FPI; fasting plasma ins
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Serum alanine aminotransferase; Type 2 diabetes; Cardiovascular disease; Non-alcoholic fatty liver disease; ALT; alanine aminotransferase; AST; aspartate aminotransferase; aP; alkaline phosphatase; Q; quartile; BMI; body mass index; CHD; coronary heart di
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; HTN; hypertension; BP; blood pressure; LDL; low-density lipoprotein; HDL; high-density lipoprotein; BMI; body mass index; HOMA-IR; homeostasis model assessment of insulin resistance; WBC; white blood cell; AST; aspartate aminotransferase; ALT; alanine ami
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BP; blood pressure; HOMA-IR; homeostasis model assessment of insulin resistance; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration; Ferritin; Diabetes; Cohort;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; ALT; alanine aminotransferase; BMI; body mass index; CI; confidence interval; FLI; fatty liver index; HEPA; health-enhancing physically active; HOMA-IR; homeostasis model assessment of insulin resistance; HDL-C; high-density lipoprotein-cholesterol; LDL-C
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Ferritin; Insulin resistance, HOMA-IR; IR; insulin resistance; BP; blood pressure; LDL; low-density lipoprotein; HDL; high-density lipoprotein; BMI; body mass index; HOMA-IR; homeostasis model assessment of insulin resistance; WBC; white blood cell; AST;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; AUC; area under curve; CAT; catalase; DCFH; dichlorofluorescein; DNPH; dinitrophenylhydrazine; GSH; glutathione; GPx; glutathione peroxidase; GR; glutathione reductase; GST; glutathione-S-transferase; GTT; glucose tolerance test; HO-1; heme oxygenase; HOM
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; FLI; fatty liver index; HEPA; health-enhancing physically active; HOMA-IR; homeostasis model assessment of insulin resistance; HDL-C; high-density lipoprotein-cholesterol; LDL-C;
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Low muscle mass; Sarcopenia; Metabolic syndrome; Obesity; Young adults; Insulin resistance; ASM; appendicular skeletal muscle mass; ASM/Wt; ASM divided by weight; BMI; body mass index; BP; blood pressure; CI; confidence interval; CVD; cardiovascular disea
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; NAFLD; non-alcoholic fatty liver disease; IHTG; intrahepatic triglyceride; BMI; body mass index; SBP; systolic blood pressure; DBP; diastolic blood pressure; FPG; fasting plasma glucose; HOMA-IR; homeostasis model assessment of insulin resistance; TG; tri
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; AMRF; Auckland Medical Research Foundation; AST; aspartate aminotransferase; CLA; conjugated linoleic acid; DGAT1; diglyceride acyltransferase 1; F20; fetal day 20; FASN; fatty acid synthase; HDL; high-density lipoprotein cholesterol; HOMA-IR; homeostasis
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; 12(13)Ep-9-KODE; 2(13)Epoxy-9-ketooctadecadienoic acid; % en; % of energy; ALA; α-Linolenic acid; ArA; Arachidonic acid; AUC; Area under the curve; AutOx; Auto-oxidation; BHT; 2,6-Di-tert-butyl-4-methylphenol; COX; Cyclooxygenase; CYP; Cytochrome P450; D
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; HFS; high-fat sucrose; TJPs; tight-junction proteins; HOMA-IR; homeostasis model assessment of insulin resistance; LPS; lipopolysaccharide; LBP; LPS-binding protein; IL-18; interleukin- 18; NFκβ; nuclear factor kappa β; TNF-α; tumour necrosis factor Î
Keywords: ارزیابی مدل هومیوستاز مقاومت به انسولین; Food timing; Leptin; Ghrelin; Adiponectin; Feeding behavior; Metabolic syndrome; ACC; acetyl CoA carboxylase; AdipoRS; adiponectin receptors; AgRP; agouti-related protein; ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; AST; aspartate a